Related Experiment Videos

Effect of a quality improvement intervention to decrease delays in antibiotic delivery in pediatric febrile

Veronica Moreira Amado1, Guilherme Pinho Vilela, Abdias Queiroz

  • 1Department of Internal Medicine, University of Brasília, Brasília, DF, Brazil 70910.

Journal of Critical Care
|July 13, 2010
PubMed

Insights

A simple quality improvement intervention significantly reduced antibiotic delivery time in pediatric intensive care unit patients with febrile neutropenia, improving adherence to early antibiotic administration guidelines.

Area of Science:

  • Pediatric critical care medicine
  • Oncology
  • Infectious diseases

Background:

  • Severe sepsis guidelines recommend antibiotics within 1 hour.
  • Febrile neutropenia in pediatric oncology patients requires prompt antibiotic treatment.
  • Timely antibiotic delivery is crucial for managing severe infections in immunocompromised children.

Purpose of the Study:

  • To evaluate if pre-positioned antibiotics in emergency carts reduce time to administration.
  • To assess the impact of this intervention on medical complications in pediatric oncology patients with febrile neutropenia.

Main Methods:

  • A before-and-after observational study design was used.
  • The study included pediatric patients (age ≤18) in the ICU with chemotherapy-induced febrile neutropenia.
  • Antibiotic delivery times were retrospectively collected from 25 patient charts for each period.

Main Results:

  • Median time to antibiotic delivery decreased from 164 to 55 minutes post-intervention.
  • The percentage of patients receiving antibiotics within 60 minutes increased from 0% to 52% (P < .001).
  • Complication rates remained low in both pre- and post-intervention periods.

Conclusions:

  • A simple quality improvement intervention effectively reduced antibiotic administration time.
  • This intervention supports guideline adherence for early antibiotic use in pediatric ICU patients.
  • Pre-positioning antibiotics is a feasible strategy to improve sepsis care in vulnerable pediatric populations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...